Acuta Capital Partners, LLC Bio Xcel Therapeutics, Inc. Transaction History

Acuta Capital Partners, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$37.44 - $64.63 $12.7 Million - $22 Million	-340,500 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$17.62 - $58.71 $449,310 - $1.5 Million	25,500 Added 8.1%	340,500 $18.1 Million
Q1 2020 May 15, 2020	BUY	$12.26 - $41.14 $3.86 Million - $13 Million	315,000 New	315,000 $7.04 Million

7.26M

101K

205K

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $16.8M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

Get notified when there are updates to the investment portfolio of Acuta Capital Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Acuta Capital Partners, LLC with notifications on news.